Remove portal
article thumbnail

PCI to integrate Aadhaar authentication to DIGI-PHARMed portal

AuroBlog - Aurous Healthcare Clinical Trials blog

The Pharmacy Council of India (PCI) has requested all pharmacy institutions to fill the correct data as per Aadhaar card details in the Standard Inspection Format (SIF) and PCI portal as part of its process of integrating Aadhaar authentication for the faculties, pharmacists, students and pharmacy institutions in the portal as per the recent notification (..)

Pharmacy 158
article thumbnail

DCC asks SLAs to set deadline for manufacturers to add product details to Sugam portal

AuroBlog - Aurous Healthcare Clinical Trials blog

The Drugs Consultative Committee (DCC), the advisory committee of the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws across the country, has recommended to all the States to set a deadline for the manufacturing companies to upload all the formulation details in the Sugam portal, (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NABH launches new online application portal for its SHCO Accreditation Programme

AuroBlog - Aurous Healthcare Clinical Trials blog

In order to ease out application experience, security and faster turnaround time, the National Accreditation Board for Hospitals and Healthcare Providers (NABH) has launched new online application portal for its Small Healthcare Organizations (SHCO) (maximum sanctioned bed strength of 50) Accreditation Programme.

article thumbnail

SQZ, Portal founder Armon Sharei on starting over in biotech

Bio Pharma Dive

After his first biotech startup was sold off in parts, Sharei is applying the lessons he’s learned to a new company with a different business model.

248
248
article thumbnail

PHIN-214 by PharmaIN for Portal Hypertension: Likelihood of Approval

Pharmaceutical Technology

PHIN-214 is under clinical development by PharmaIN and currently in Phase I for Portal Hypertension. According to GlobalData, Phase I…

article thumbnail

PHIN-214 by PharmaIN for Portal Hypertension: Likelihood of Approval

Pharmaceutical Technology

PHIN-214 is under clinical development by PharmaIN and currently in Phase I for Portal Hypertension.

article thumbnail

Breath test can reveal signs of liver cirrhosis and portal hypertension

Outsourcing Pharma

Owlstone Medical's exegenous volatile organic compound (EVOC) breath test can reveal signs of liver cirrhosis and portal hypertension, a study has found.